ESC Premium Access

Baseline triglycerides and non-HDL-C and apoB goal attainment in the ORION-10 and ORION-11 trials

Congress Presentation

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
4 followers

7 more presentations in this session

Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: results from the Rotterdam Study

Speaker: Ms J. Pavlovic (Rotterdam, NL)

Thumbnail

Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study

Speaker: Professor K. Ray (London, GB)

Thumbnail

Non-statin lipid-lowering therapy in coronary atherosclerosis regression: A meta-analysis and meta-regression.

Speaker: Doctor L. Lobo (Buenos Aires, AR)

Thumbnail

REDUCE-IT: total ischemic events reduced across the full range of baseline LDL cholesterol and other key subgroups

Speaker: Professor D. Bhatt (Boston, US)

Thumbnail

REDUCE-IT: accumulation of data across prespecified interim analyses to final results

Speaker: Professor B. Olshansky (Iowa City, US)

Thumbnail

Access the full session

Non-statin Treatment of Dyslipidemia

Speakers: Professor K. Ray, Ms J. Pavlovic, Professor K. Ray, Doctor L. Lobo, Professor D. Bhatt...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk